The American Academy of Pediatrics recommends Beyfortus

The AAP has also added Beyfortus to the approved immunization schedule to prevent RSV in babies.

What is Beyfortus?

Beyfortus is a prescription medicine used to help prevent a serious lung disease caused by Respiratory Syncytial Virus (RSV) in:

Newborns and babies under 1 year of age born during or entering their first RSV season.
Children up to 24 months of age who remain at risk of severe RSV disease through their second RSV season.

Prescribing Information

Press Release

What is RSV?

RSV is a highly contagious virus that can lead to respiratory illness in babies, including lung infections. Without a fully developed immune system, all babies under 1 year – even healthy ones – are at serious risk of getting RSV.

When will Beyfortus be available for my baby?

Now that Beyfortus has been approved by the FDA, we are working hard to get it into the hands of doctors around the country to prevent a serious lung disease caused by RSV.

Successful trials
FDA approval
Accepting orders from doctors
Ask your baby’s doctor about Beyfortus now

Beyfortus in the news

Learn more about the AAP’s recommendation

View the AAP press release

Discover what the CDC has to say

View the CDC press release

FAQs

Beyfortus is an antibody that contains nirsevimab-alip which is used to help prevent RSV disease for 5 months. It is not known if Beyfortus is safe and effective in children older than 24 months of age.

RSV symptoms can include a runny nose, sneezing, congestion, coughing, fever, decreased appetite, and wheezing. In babies with RSV, the only symptoms may be irritability, decreased activity, and breathing difficulties, according to the CDC.   For more information on RSV symptoms in babies, talk to your doctor or pediatrician.

RSV can often mimic a cold or the flu. But as the infection becomes more severe, so do the symptoms. For more information on the differences between RSV and the flu, talk to your doctor or pediatrician.

Since most RSV cases are mild, testing is usually not required to diagnose the infection. However, depending on your baby’s medical history and the time of year, their doctor may do a nose swab or blood test to look for viruses and check white blood cell counts. In more severe RSV cases where hospitalization is required, your doctor may do a chest X-ray or CT scan to check for lung complications.   For more information on how RSV is diagnosed, talk to your doctor or pediatrician.

IMPORTANT SAFETY INFORMATION

Your child should not take Beyfortus if your child has a history of serious allergic reactions to nirsevimab-alip or any of the ingredients in Beyfortus.

Before your child receives Beyfortus, tell your healthcare provider about all of your child’s

Your child should not take Beyfortus if your child has a history of serious allergic reactions to nirsevimab-alip or any of the ingredients in Beyfortus.

Before your child receives Beyfortus, tell your healthcare provider about all of your child’s medical conditions, including if your child:

has ever had a reaction to Beyfortus.
has bleeding or bruising problems. If your child has a problem with bleeding or bruises easily, an injection could cause a problem.

Tell your healthcare provider about all the medicines your child takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your infant should not receive a medicine called palivizumab if they have already received Beyfortus in the same RSV season.

Serious allergic reactions have happened with other medicines like Beyfortus. Get medical help right away if your child has any of the following signs or symptoms of a serious allergic reaction:

swelling of the face, mouth, or tongue
difficulty swallowing or breathing
unresponsiveness
bluish color of skin, lips, or under fingernails
muscle weakness
severe rash, hives, or itching

The most common side effects of Beyfortus include rash and pain, swelling, or hardness at the site of your child’s injection. These are not all the possible side effects of Beyfortus. Call your healthcare provider if you have questions about side effects.

Please see full Prescribing Information, including Patient Information, for more details.

INDICATION

Beyfortus is a prescription medicine used to help prevent a serious lung disease caused by Respiratory Syncytial Virus (RSV) in:

Newborns and babies under 1 year of age born during or entering their first RSV season.
Children up to 24 months of age who remain at risk of severe RSV disease through their second RSV season.

Please see full Prescribing Information, including Patient Information, for more details.

Click here to learn more about Sanofi’s commitment to fighting counterfeit drugs.

MAT-US-2303822-v4.0-10/2023

The American Academy of Pediatrics recommends Beyfortus

What is Beyfortus?

What is RSV?

When will Beyfortus be available for my baby?

Sign up to stay in the loop!

Beyfortus in the news

Read more about the FDA’s approval

Learn more about the AAP’s recommendation

Discover what the CDC has to say

FAQs

How does Beyfortus help protect against illness caused by RSV?

What are the symptoms of RSV?

How is RSV different from the flu?

How is RSV diagnosed?

Let family and friends know Beyfortus is now approved.

IMPORTANT SAFETY INFORMATION

INDICATION